文献速递神经肿瘤神经重症小儿神经外科与脑积水

颅脑手术硬膜修复中自体与非自体硬膜替代物的并发症发生率均为中等水平

Dural Repair in Cranial Surgery Is Associated with Moderate Rates of Complications with Both Autologous and Nonautologous Dural Substitutes.
PubMed 文献 · World Neurosurg · 2018-01-31

该研究系统检索PubMed数据库2007至2017年发表的硬膜成形术文献,对462例病例进行定量合成分析。硬膜成形术最常见的指征为肿瘤切除(53%),所有类型硬膜替代物的累积并发症发生率为11%,三种类型替代物间并发症发生率无显著差异。作者指出未来需在更大的前瞻性队列中确定此类手术的安全性和有效性。

要点

  • 硬膜成形术最常见指征为肿瘤切除,占53%。
  • 所有类型硬膜替代物的累积并发症发生率为11%。
  • 三种硬膜替代物间并发症发生率无显著差异。

核心结论

  • 硬膜替代物常用于多种颅脑手术以确保硬膜闭合,本研究提供了对硬膜成形术实践的更深入认识,并强调该手术相关的并发症发生率为中等水平。
  • 作者指出未来需在更大的前瞻性队列中确定此类手术的安全性和有效性。

研究设计与样本

  • 系统检索PubMed数据库,纳入过去十年(2007-2017年)发表的描述硬膜成形术的研究。
  • 对临床数据进行分解分析,比较生物性移植物与合成移植物。
  • 定量合成共纳入462例病例。

主要发现

  • 硬膜成形术最常见的指征为肿瘤切除(53%)。
  • 同种异体移植物在Chiari畸形减压术中较异种移植物和合成移植物更常用(P < 0.001)。
  • 异种移植物在急性硬膜下血肿清除的去骨瓣减压术中较同种异体移植物和合成移植物更常用(P < 0.001)。
  • 合成移植物在肿瘤病例中较生物性移植物更常用(P = 0.002)。
  • 所有类型硬膜替代物的累积并发症发生率为11%,三种类型硬膜替代物间并发症发生率无显著差异。

关键数值与推荐

  • 硬膜成形术最常见指征为肿瘤切除,占53%。
  • 所有类型硬膜替代物的累积并发症发生率为11%。
  • 三种类型硬膜替代物间并发症发生率无显著差异。
  • 同种异体移植物在Chiari畸形减压术中较异种移植物和合成移植物更常用(P < 0.001)。
  • 异种移植物在急性硬膜下血肿清除的去骨瓣减压术中较同种异体移植物和合成移植物更常用(P < 0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 未来需在更大的前瞻性队列中确定此类手术的安全性和有效性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Duraplasty, a common neurosurgical intervention, involves synthetic or biological graft placement to ensure dural closure. The objective of this study is to advance our understanding of the use of dural substitutes in cranial surgery. METHODS: The PubMed database was systematically searched to identify studies published over the past decade (2007-2017) that described duraplasty procedures. Clinical data were disaggregated and analyzed for the comparisons of biological versus synthetic grafts. RESULTS: A total of 462 cases were included in the quantitative synthesis. Overall, the most common indication for duraplasty was tumor resection (53%). Allografts were more frequently used in decompression for Chiari malformations compared with xenografts and synthetic grafts (P < 0.001). Xenografts were more frequently used in decompressive hemicraniectomy procedures for evacuation of acute subdural hematomas over allografts and synthetics (P < 0.001). Synthetic grafts were more frequently used in tumor cases than biological grafts (P = 0.002). The cumulative complication rate for dural substitutes of all types was 11%. There were no significant differences in complication rates among the 3 types of dural substitutes. CONCLUSIONS: Dural substitutes are commonly used to ensure dural closure in a variety of cranial procedures. This study provides greater insight into duraplasty practices and highlights the moderate complication rate associated with the procedure. Future studies are needed to determine the safety and efficacy of such procedures in larger prospective cohorts.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Azzam D, Romiyo P, Nguyen T, et al. Dural Repair in Cranial Surgery Is Associated with Moderate Rates of Complications with Both Autologous and Nonautologous Dural Substitutes. World Neurosurg. 2018. PMID: 29374609. doi:10.1016/j.wneu.2018.01.115

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。